ERBB2 and breast carcinoma: In this study, a combination of immunohistochemistry (IHC) and quantitative PCR methods of determining expression of Estrogen Receptors (ER), Progesterone Receptors (PR) and Human Epidermal Growth Factor 2 (HER-2) in Breast cancer tissues were compared.